Business ❯Pharmaceutical Industry

Pricing Strategies

Market Competition Direct-to-Consumer Sales Government Regulations Pharmacy Benefit Managers Market Availability Cost Management Discounts Drug Pricing Profit Margins

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Americans pay significantly more for GLP-1 weight-loss drugs despite billions in public funding for their development.

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Novo Nordisk Launches Wegovy in France Without Reimbursement

Texas Sues Insulin Manufacturers and PBMs for Price Inflation

Senate Grills Novo Nordisk CEO Over High U.S. Prices for Ozempic and Wegovy

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations